Perspective Therapeutics (CATX) Goodwill (2023 - 2024)
Perspective Therapeutics (CATX) posted Goodwill of $24.1 million for Q3 2024, little changed sequentially from $24.1 million in Q2 2024, and down 11.78% YoY from $27.3 million in Q4 2023.
Perspective Therapeutics (CATX) Goodwill (2023 - 2024) Analysis & Trends
Perspective Therapeutics has reported Goodwill for 2 years, with the latest figure at $24.1 million in Q3 2024.
- Quarterly Goodwill fell 11.78% year-over-year to $24.1 million in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $24.1 million (down 11.78% YoY) and the FY2023 annual result came in at $24.1 million, changed N/A from the prior year.
- Goodwill was little changed at $24.1 million in Q3 2024 per CATX's latest filing, from $24.1 million in the prior quarter.
- Over five years, Goodwill peaked at $27.3 million in Q2 2023 and troughed at $24.1 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn |
| 10 | Perspective Therapeutics | 387.89 Mn | 387.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 24.10 Mn |
| Jun 30, 2024 | 24.10 Mn |
| Mar 31, 2024 | 24.06 Mn |
| Dec 31, 2023 | 24.10 Mn |
| Sep 30, 2023 | 27.32 Mn |
| Jun 30, 2023 | 27.32 Mn |
| Mar 31, 2023 | 27.30 Mn |